<code id='AA0300F5F6'></code><style id='AA0300F5F6'></style>
    • <acronym id='AA0300F5F6'></acronym>
      <center id='AA0300F5F6'><center id='AA0300F5F6'><tfoot id='AA0300F5F6'></tfoot></center><abbr id='AA0300F5F6'><dir id='AA0300F5F6'><tfoot id='AA0300F5F6'></tfoot><noframes id='AA0300F5F6'>

    • <optgroup id='AA0300F5F6'><strike id='AA0300F5F6'><sup id='AA0300F5F6'></sup></strike><code id='AA0300F5F6'></code></optgroup>
        1. <b id='AA0300F5F6'><label id='AA0300F5F6'><select id='AA0300F5F6'><dt id='AA0300F5F6'><span id='AA0300F5F6'></span></dt></select></label></b><u id='AA0300F5F6'></u>
          <i id='AA0300F5F6'><strike id='AA0300F5F6'><tt id='AA0300F5F6'><pre id='AA0300F5F6'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:2
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          'Make People Better': The CRISPR babies story you probably don't know
          'Make People Better': The CRISPR babies story you probably don't know

          Thebirthofgeneticallyengineeredtwingirls,nicknamedLuluandNana,atanundisclosedhospitalinChina,wasanno

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Biotech execs pursue obesity drug boom: ‘It’s the early innings’

          ElaineChenofSTAT,upperleft,talkedaboutobesitydrugswith,clockwise,RaymondStevenofStructureTherapeutic